Prolonged Dexmedetomidine Infusion as an Adjunct in Treating Sedation-Induced Withdrawal
- 1 April 2003
- journal article
- case report
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 96 (4) , 1054-1055
- https://doi.org/10.1213/01.ane.0000050773.70232.08
Abstract
Dexmedetomidine, an alpha(2)-adrenoceptor agonist, is indicated for sedating patients on mechanical ventilation. It has been approved by the Food and Drug Administration for 24-h use. This is a report concerning a patient in whom a continuous infusion of dexmedetomidine was safely used for a week to help in averting frank withdrawal symptoms from an opioid and benzodiazepines.Keywords
This publication has 15 references indexed in Scilit:
- Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adultCritical Care Medicine, 2002
- α2A‐Adrenergic receptors are present in μ‐opioid receptor containing neurons in rat medial nucleus tractus solitariusSynapse, 2001
- Alpha‐2 and imidazoline receptor agonistsTheir pharmacology and therapeutic roleAnaesthesia, 1999
- Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimensCritical Care Medicine, 1998
- Dissociation of Tolerance and Dependence for Opioid Peripheral Antinociception in RatsJournal of Neuroscience, 1997
- Effect of ?2-adrenoceptor agonists on the expression of morphine-withdrawal in ratsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1992
- Clonidine and other alpha2 adrenergic agonists: Strategies for the rational use of these novel anesthetic agentsJournal of Clinical Anesthesia, 1988
- Benzodiazepine Withdrawal: outcome in 50 patientsBritish Journal of Addiction, 1987
- Effects of Clonidine on Narcotic Requirements and Hemodynamic Response during Induction of Fentanyl Anesthesia and Endotracheal IntubationAnesthesiology, 1986
- The effect of lesions of ascending noradrenaline pathways on sleep and waking in the ratBrain Research, 1974